Discover 156 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Fort Smith AR, Branson MO, Joplin MO, Springfield MO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase 3, Recruiting
Active & Responsive
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Fort Smith AR, Branson MO, Joplin MO, Springfield MO,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07283939
Recruiting
Active & Responsive
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Fort Smith AR, Branson MO, Joplin MO, Springfield MO,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07091617
Recruiting
Active & Responsive
Fasted vs. Fed State Exercise
for
Obesity, Exercise, Weight Loss
Location: Fort Smith AR
Sponsor: Arkansas Colleges of Health Education
Sex: All
Age: 18 - 59
Code: NCT07487090
Phase 2, Recruiting
Combining a Smartphone App With Medications to Manage Heavy Drinking
Get alerts for new trials in your area by subscribing now
Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study
for
Decision-Making, Patient Care, Treatment Decisions
Location: Fayetteville AR, Albuquerque NM, Roanoke VA
Sponsor: University of Arkansas, Fayetteville
Sex: All
Age: 18+
Code: NCT07842367
Phase 2, Recruiting
Telehealth Multi-Component Optional Model (MOM) Study
for
Maternal Health
Location: Fayetteville AR, Springdale AR, Fort Smith AR,
Sponsor: University of Arkansas
Sex: Female
Age: 18 - 44
Code: NCT06095960
Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
for
Parkinson's Disease
Location: Fayetteville AR, Lawrence KS, Shreveport LA,
Sponsor: Parkinson's Foundation
Sex: All
Age: 18+
Code: NCT04994015
Recruiting
Protein and Exercise for Postmenopausal Women's Wellbeing
for
Postmenopausal
Location: Fayetteville AR
Sponsor: University of Arkansas, Fayetteville
Sex: Female
Age: 0+
Code: NCT06849817
Recruiting
Dental-Child Interaction Training
for
Behavior and Behavior Mechanisms, Child Behavior
Location: Fayetteville AR, Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT06138405
Recruiting
GAINS Expert Guiding Technology to Coach Life Skill Teaching
for
GAINS Expert Guiding Technology to Coach Life Skill Teaching
Location: Fayetteville AR
Sponsor: Guiding Technologies Corporation
Sex: All
Age: 3 - 10
Code: NCT07203105
Recruiting
Time Restricted Feeding, Muscle, and Metabolism
for
Overweight, Obesity
Location: Fayetteville AR
Sponsor: University of Arkansas, Fayetteville
Sex: All
Age: 25 - 50
Code: NCT04949451
Recruiting
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
for
Aortic Aneurysm, Abdominal
Location: Washington AR, Columbia MO, St Louis MO, Maywood IL,
Sponsor: Rijnstate Hospital
Sex: All
Age: 18+
Code: NCT05484115
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Fayetteville AR, Springdale AR, Rogers AR, Paris TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase 3, Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Fayetteville AR, Kansas City KS, Dallas TX, St Louis MO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase 3, Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Fayetteville AR, Springdale AR, Rogers AR, Paris TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer